Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis

May 22 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB INITIATES GLOBAL PHASE 2 CLINICAL TRIAL EVALUATING
ZL-1102 AS A TOPICAL TREATMENT FOR CHRONIC PLAQUE PSORIASIS

Source text for Eikon:  ID:nBw7dQp5ha 
Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news